Showing results (1861-1870 of 2,022) with videos related to
Sort By:
Pageof 203
HGG Advances|April 28, 2024
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infectionAstrid Marchal, Elizabeth T Cirulli, Iva Neveux, et al.Nature Communications|April 13, 2016
T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.European Journal of Cancer (Oxford, England : 1990)|November 29, 2020
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK)Karolina Nemes, Susanne Bens, Denis Kachanov, et al.Revista Brasileira De Epidemiologia = Brazilian Journal of Epidemiology|October 3, 2019
The QualiRede intervention: improving the performance of care continuum in HIV, congenital syphilis, and hepatitis C in health regionsMaria Ines Battistella Nemes, Elen Rose Lodeiro Castanheira, Ana Maroso Alves, et al.Vaccine|July 17, 2026
Conference report: airway mucosal sampling and immune analysisJoshua Rosenheim, Bonnie Bender, Jill Gilmour, et al.The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 27, 2023
Learning slopes in early-onset Alzheimer's diseaseDustin B Hammers, Sára Nemes, Taylor Diedrich, et al.Annals of the New York Academy of Sciences|January 14, 2022
Innovative vaccine approaches-a Keystone Symposia reportJennifer Cable, Rino Rappuoli, Elizabeth J Klemm, et al.Cancers|May 14, 2022
Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging PopulationKarolina Nemes, Pascal D Johann, Mona Steinbügl, et al.The Lancet. Infectious Diseases|March 8, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trialÁlvaro H Borges, Marisa Russell, Dereck Tait, et al.Pageof 203